CalciMedica shares fell after the company stopped its Phase 2 KOURAGE trial for Auxora due to safety concerns.
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...
LUND, SE / ACCESS Newswire / January 28, 2026 /Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA)(STO:CANTA) today ...
As of Wednesday, January 28, CalciMedica, Inc.’s CALC share price has dipped by 82.41%, which has investors questioning if ...
News Medical on MSN
Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetes
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...
CalciMedica’s stock nosedived after the biotech abandoned a phase 2 study of its calcium release-activated calcium (CRAC) ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
Safety concern warrants reevaluation of study design, including enrollment criteria Potential future trial with Auxora in AKI to be evaluated after data analysis LA ...
The Department for Work and Pensions has published the complete list of 178 medical conditions that qualify for Personal Independence Payment worth up to £187.45 per week ...
I knew that people had strong feelings about kibble. But dog food was a gateway into a whole host of MAHA-esque ideas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results